Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?

Standard pharmacological therapy in Takotsubo syndrome (TTS) is still debated and there is a lack of prospective data. In their recent work in BMC Cardiovascular Disorders Abanador-Kamper et al. found that stroke in TTS has an event rate of 2.8% after 30 days and 4.2% after 12 months and they questi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cardiovasc Disord
Asıl Yazarlar: Santoro, Francesco, Stiermaier, Thomas, Guastafierro, Francesca, Tarantino, Nicola, Eitel, Ingo, Brunetti, Natale Daniele
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Correspondence
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206855/
https://ncbi.nlm.nih.gov/pubmed/30373518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0930-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller